India Diabetes Care Devices Market Outlook to 2022 - Glucose Monitoring and Insulin Delivery

GlobalData
108 Pages - GLDATA57716
$5,995.00

Summary

GlobalData’s new report, "India Diabetes Care Devices Market Outlook to 2022", provides key market data on the India Diabetes Care Devices market. The report provides value, in millions of US dollars and volume (in units) within market categories - Glucose Monitoring and Insulin Delivery.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- Market size for Diabetes Care Devices market categories - Glucose Monitoring and Insulin Delivery.
- Annualized market revenues (USD million) and volume (units) data for each of the market categories. Data is provided from 2008 to 2015 and forecast to 2022.
- 2015 company shares and distribution shares data for Diabetes Care Devices market.
- Global corporate-level profiles of key companies operating within the India Diabetes Care Devices market.
- Key players covered include LifeScan Inc, Bayer HealthCare AG, F. Hoffmann-La Roche Ltd and others.

Reasons to buy

- Develop business strategies by identifying the key market segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.

Companies Mentioned

F. Hoffmann-La Roche Ltd
Eli Lilly and Company
Bayer HealthCare AG
Becton Dickinson and Co
LifeScan Inc
Hindustan Syringes and Medical Devices Ltd
Novo Nordisk A/S
Arkray Inc
HTL-Strefa SA
I-Sens Inc.
DexCom Inc
Nipro Corp
Abbott Laboratories

'

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 6
2 Introduction 7
2.1 What Is This Report About? 7
2.2 Diabetes Care Devices Market Segmentation 7
2.3 Definitions of Markets Covered in the Report 8
3 Diabetes Care Devices Market, India 10
3.1 Diabetes Care Devices Market, India, Revenue ($m), 2008-2022 10
3.2 Diabetes Care Devices Market, India, Revenue Mix ($m), 2015 12
3.3 Diabetes Care Devices Market, India, Category Contribution by Revenue ($m), 2015 13
3.4 Diabetes Care Devices Market, India, Revenue ($m), 2008-2015 14
3.5 Diabetes Care Devices Market, India, Revenue ($m), 2015-2022 16
3.6 Diabetes Care Devices Market, India, Volume (Units), 2008-2022 18
3.7 Diabetes Care Devices Market, India, Volume (Units), 2008-2015 19
3.8 Diabetes Care Devices Market, India, Volume (Units), 2015-2022 21
3.9 Diabetes Care Devices Market, India, Company Share by Revenue ($m), 2015 23
4 Glucose Monitoring Market, India 25
4.1 Glucose Monitoring Market, India, Revenue Mix ($m), 2015 25
4.2 Glucose Monitoring Market, India, Segment Contribution (%), 2015 26
4.3 Glucose Monitoring Market, India, Revenue ($m), 2008-2015 27
4.4 Glucose Monitoring Market, India, Revenue ($m), 2015-2022 29
4.4.1 Blood Glucose Meters Market, India, Revenue ($m), by Segment, 2008-2015 31
4.4.2 Blood Glucose Meters Market, India, Revenue ($m), by Segment, 2015-2022 33
4.5 Glucose Monitoring Market, India, Volume (Units), 2008-2015 35
4.6 Glucose Monitoring Market, India, Volume (Units), 2015-2022 37
4.6.1 Blood Glucose Meters Market, India, Volume (Units), by Segment, 2008-2015 39
4.6.2 Blood Glucose Meters Market, India, Volume (Units), by Segment, 2015-2022 41
4.7 Glucose Monitoring Market, India, Distribution Share by Revenue ($m), 2014-2015 43
4.8 Glucose Monitoring Market, India, Company Share by Revenue ($m), 2015 44
5 Insulin Delivery Market, India 46
5.1 Insulin Delivery Market, India, Revenue Mix ($m), 2015 46
5.2 Insulin Delivery Market, India, Segment Contribution (%), 2015 47
5.3 Insulin Delivery Market, India, Revenue ($m), 2008-2015 48
5.4 Insulin Delivery Market, India, Revenue ($m), 2015-2022 50
5.4.1 Insulin Pens Market, India, Revenue ($m), by Segment, 2008-2015 52
5.4.2 Insulin Pumps Market, India, Revenue ($m), by Segment, 2008-2015 54
5.4.3 Insulin Pens Market, India, Revenue ($m), by Segment, 2015-2022 55
5.4.4 Insulin Pumps Market, India, Revenue ($m), by Segment, 2015-2022 57
5.5 Insulin Delivery Market, India, Volume (Units), 2008-2015 58
5.6 Insulin Delivery Market, India, Volume (Units), 2015-2022 60
5.6.1 Insulin Pens Market, India, Volume (Units), by Segment, 2008-2015 62
5.6.2 Insulin Pumps Market, India, Volume (Units), by Segment, 2008-2015 64
5.6.3 Insulin Pens Market, India, Volume (Units), by Segment, 2015-2022 65
5.6.4 Insulin Pumps Market, India, Volume (Units), by Segment, 2015-2022 67
5.7 Insulin Delivery Market, India, Distribution Share by Revenue ($m), 2014-2015 68
5.8 Insulin Delivery Market, India, Company Share by Revenue ($m), 2015 69
6 Overview of Key Companies in India, Diabetes Care Devices Market 71
6.1 F. Hoffmann-La Roche Ltd 71
6.1.1 Company Overview 71
6.2 Eli Lilly and Company 71
6.2.1 Company Overview 71
6.3 Bayer HealthCare AG 71
6.3.1 Company Overview 71
6.4 Becton Dickinson and Co 71
6.4.1 Company Overview 71
6.5 LifeScan Inc 72
6.5.1 Company Overview 72
6.6 Hindustan Syringes and Medical Devices Ltd 72
6.6.1 Company Overview 72
6.7 Novo Nordisk A/S 72
6.7.1 Company Overview 72
6.8 Arkray Inc 73
6.8.1 Company Overview 73
6.9 HTL-Strefa SA 73
6.9.1 Company Overview 73
6.10 I-Sens Inc. 73
6.10.1 Company Overview 73
6.11 DexCom Inc 73
6.11.1 Company Overview 73
6.12 Nipro Corp 74
6.12.1 Company Overview 74
6.13 Abbott Laboratories 74
6.13.1 Company Overview 74
7 Diabetes Care Devices Market Pipeline Products 75
8 Financial Deals Landscape 76
8.1 Partnerships 76
8.1.1 Tandem Diabetes Care Enters into Licensing Agreement with TypeZero Technologies 76
8.1.2 Medtronic and Qualcomm Life Enter into Co-Development Agreement 77
8.1.3 Metabolon Enters into Licensing Agreement with Synlab 78
9 Recent Developments 79
9.1 Corporate Communications 79
9.1.1 Sep 19, 2016: Biocon Appoints Suresh Subramanian as Head of Branded Formulations (India) Business 79
9.1.2 Jun 02, 2016: Sanofi India Announces Appointment of Chairman of the Board of Directors 79
9.2 Financial Announcements 80
9.2.1 Oct 20, 2016: Biocon Q2 FY17 Revenue Up 21%; EBITDA Up 45% 80
9.2.2 Oct 18, 2016: Theravance Biopharma to Present New Data from Multiple Studies of VIBATIV (telavancin), Including Ongoing TOUR Observational Patient Registry, at IDWeek 2016 82
9.2.3 Oct 18, 2016: Amneal Launches First Vagifem Generic 85
9.2.4 Aug 01, 2016: Piramal Enterprises Consolidated Results for the First Quarter ended 30 June 2016 85
9.2.5 Jul 21, 2016: Biocon Reports a Strong Q1 FY17 Revenues at Rs. 952 Crore, Up by 11%; EBITDA Up 15% to Rs. 271 Crore; Net Profit Up 17% at Rs. 147 Crore 87
9.2.6 Apr 26, 2016: Biocon Q4FY16 Net Profit at Rs 361 Cr Revenue Crosses Rs 1,000 Cr; Up 17% 90
9.2.7 Apr 26, 2016: Biocon : Q4FY16 Net Profit at Rs 361 Cr; Revenue Crosses Rs 1,000 Cr; Up 17% 93
9.2.8 Feb 08, 2016: Piramal Enterprises Consolidated Results for the Q3 FY2016 and 9M FY2016 95
9.2.9 Feb 04, 2016: Sanofi India Announces Results for the Quarter & Year Ended December 31, 2015 98
9.2.10 Jan 21, 2016: Biocon Q3FY16 Net Profit Up 13% at Rs 103 Crore, EBITDA Increases 23% to Rs 209 Crore, Revenues at Rs 857 Crore, up by 10% 98
9.3 Legal And Regulatory 101
9.3.1 Dec 13, 2016: TUV Certification for the Bengaluru Facility 101
9.4 Other Significant Developments 101
9.4.1 Aug 03, 2016: Cesca Therapeutics Announces Promising Results From 40-Month Follow-Up of Patients Enrolled in Critical Limb Ischemia Feasibility Study 101
9.5 Strategy And Business Planning 102
9.5.1 Sep 28, 2016: Piramal plans to expand its API development & manufacturing capabilities at Digwal plant 102
9.5.2 Jan 25, 2016: AstraZeneca partners with peers and academia to establish translational research fund 103
10 Appendix 104
10.1 Research Methodology 105
10.1.1 Coverage 105
10.1.2 Secondary Research 105
10.1.3 Primary Research 106
10.1.4 Company Share Analysis 106
10.1.5 Distribution Share Analysis 106
10.1.6 Benchmarking 107
10.2 GlobalData Consulting 107
10.3 Contact Us 107
10.4 Disclaimer 108

1.1 List of Tables
Table 1: Diabetes Care Devices Market, India, Revenue ($m), USD Constant, 2008-2022 11
Table 2: Diabetes Care Devices Market, India, Category Contribution by Revenue ($m), 2015 13
Table 3: Diabetes Care Devices Market, India, Revenue ($m), USD Constant, Historic, 2008-2015 15
Table 4: Diabetes Care Devices Market, India, Revenue ($m), USD Constant, Forecast, 2015-2022 17
Table 5: Diabetes Care Devices Market, India, Volume (Units), 2008-2022 18
Table 6: Diabetes Care Devices Market, India, Volume (Units), Historic, 2008-2015 20
Table 7: Diabetes Care Devices Market, India, Volume (Units), Forecast, 2015-2022 22
Table 8: Diabetes Care Devices Market, India, Company Share by Revenue ($m), USD Constant, 2015 24
Table 9: Glucose Monitoring Market, India, Segment Contribution (%), 2015 26
Table 10: Glucose Monitoring Market, India, Revenue ($m), USD Constant, Historic, 2008-2015 28
Table 11: Glucose Monitoring Market, India, Revenue ($m), USD Constant, Forecast, 2015-2022 30
Table 12: Blood Glucose Meters Market, India, Revenue ($m), USD Constant, Historic, 2008-2015 32
Table 13: Blood Glucose Meters Market, India, Revenue ($m), USD Constant, Forecast, 2015-2022 34
Table 14: Glucose Monitoring Market, India, Volume (Units), Historic, 2008-2015 36
Table 15: Glucose Monitoring Market, India, Volume (Units), Forecast, 2015-2022 38
Table 16: Blood Glucose Meters Market, India, Volume (Units), Historic, 2008-2015 40
Table 17: Blood Glucose Meters Market, India, Volume (Units), Forecast, 2015-2022 42
Table 18: Glucose Monitoring Market, India, Distribution Share by Revenue ($m), USD Constant, 2014-2015 43
Table 19: Glucose Monitoring Market, India, Company Share by Revenue ($m), USD Constant, 2015 45
Table 20: Insulin Delivery Market, India, Segment Contribution (%), 2015 47
Table 21: Insulin Delivery Market, India, Revenue ($m), USD Constant, Historic, 2008-2015 49
Table 22: Insulin Delivery Market, India, Revenue ($m), USD Constant, Forecast, 2015-2022 51
Table 23: Insulin Pens Market, India, Revenue ($m), USD Constant, Historic, 2008-2015 53
Table 24: Insulin Pumps Market, India, Revenue ($m), USD Constant, Historic, 2008-2015 54
Table 25: Insulin Pens Market, India, Revenue ($m), USD Constant, Forecast, 2015-2022 56
Table 26: Insulin Pumps Market, India, Revenue ($m), USD Constant, Forecast, 2015-2022 57
Table 27: Insulin Delivery Market, India, Volume (Units), Historic, 2008-2015 59
Table 28: Insulin Delivery Market, India, Volume (Units), Forecast, 2015-2022 61
Table 29: Insulin Pens Market, India, Volume (Units), Historic, 2008-2015 63
Table 30: Insulin Pumps Market, India, Volume (Units), Historic, 2008-2015 64
Table 31: Insulin Pens Market, India, Volume (Units), Forecast, 2015-2022 66
Table 32: Insulin Pumps Market, India, Volume (Units), Forecast, 2015-2022 67
Table 33: Insulin Delivery Market, India, Distribution Share by Revenue ($m), USD Constant, 2014-2015 68
Table 34: Insulin Delivery Market, India, Company Share by Revenue ($m), USD Constant, 2015 70
Table 35: Diabetes Care Devices Market Pipeline Products 75
Table 36: Tandem Diabetes Care Enters into Licensing Agreement with TypeZero Technologies 76
Table 37: Medtronic and Qualcomm Life Enter into Co-Development Agreement 77
Table 38: Metabolon Enters into Licensing Agreement with Synlab 78

1.2 List of Figures
Figure 1: Diabetes Care Devices Market, India, Revenue ($m), USD Constant, 2008-2022 10
Figure 2: Diabetes Care Devices Market, India, Revenue Mix ($m), 2015 12
Figure 3: Diabetes Care Devices Market, India, Category Contribution (%), 2015 13
Figure 4: Diabetes Care Devices Market, India, Revenue ($m), USD Constant, Historic, 2008-2015 14
Figure 5: Diabetes Care Devices Market, India, Revenue ($m), USD Constant, Forecast, 2015-2022 16
Figure 6: Diabetes Care Devices Market, India, Volume (Units), 2008-2022 18
Figure 7: Diabetes Care Devices Market, India, Volume (Units), Historic, 2008-2015 19
Figure 8: Diabetes Care Devices Market, India, Volume (Units), Forecast, 2015-2022 21
Figure 9: Diabetes Care Devices Market, India, Company Share (%) 2015 23
Figure 10: Glucose Monitoring Market, India, Revenue Mix ($m), 2015 25
Figure 11: Glucose Monitoring Market, India, Segment Contribution (%), 2015 26
Figure 12: Glucose Monitoring Market, India, Revenue ($m), USD Constant, Historic, 2008-2015 27
Figure 13: Glucose Monitoring Market, India, Revenue ($m), USD Constant, Forecast, 2015-2022 29
Figure 14: Blood Glucose Meters Market, India, Revenue ($m), USD Constant, Historic, 2008-2015 31
Figure 15: Blood Glucose Meters Market, India, Revenue ($m), USD Constant, Forecast, 2015-2022 33
Figure 16: Glucose Monitoring Market, India, Volume (Units), Historic, 2008-2015 35
Figure 17: Glucose Monitoring Market, India, Volume (Units), Forecast, 2015-2022 37
Figure 18: Blood Glucose Meters Market, India, Volume (Units), Historic, 2008-2015 39
Figure 19: Blood Glucose Meters Market, India, Volume (Units), Forecast, 2015-2022 41
Figure 20: Glucose Monitoring Market, India, Company Share (%) 2015 44
Figure 21: Insulin Delivery Market, India, Revenue Mix ($m), 2015 46
Figure 22: Insulin Delivery Market, India, Segment Contribution (%), 2015 47
Figure 23: Insulin Delivery Market, India, Revenue ($m), USD Constant, Historic, 2008-2015 48
Figure 24: Insulin Delivery Market, India, Revenue ($m), USD Constant, Forecast, 2015-2022 50
Figure 25: Insulin Pens Market, India, Revenue ($m), USD Constant, Historic, 2008-2015 52
Figure 26: Insulin Pumps Market, India, Revenue ($m), USD Constant, Historic, 2008-2015 54
Figure 27: Insulin Pens Market, India, Revenue ($m), USD Constant, Forecast, 2015-2022 55
Figure 28: Insulin Pumps Market, India, Revenue ($m), USD Constant, Forecast, 2015-2022 57
Figure 29: Insulin Delivery Market, India, Volume (Units), Historic, 2008-2015 58
Figure 30: Insulin Delivery Market, India, Volume (Units), Forecast, 2015-2022 60
Figure 31: Insulin Pens Market, India, Volume (Units), Historic, 2008-2015 62
Figure 32: Insulin Pumps Market, India, Volume (Units), Historic, 2008-2015 64
Figure 33: Insulin Pens Market, India, Volume (Units), Forecast, 2015-2022 65
Figure 34: Insulin Pumps Market, India, Volume (Units), Forecast, 2015-2022 67
Figure 35: Insulin Delivery Market, India, Company Share (%) 2015 69

$5,995.00

Research Assistance

We can help you find
data and analyses
relevant to your needs,
or prepare a custom report.

Please contact us at [email protected]
or +1 212 564 2838

 

Custom Research

Contact us to speak
with your industry analyst.

[email protected] 
+1 212 564 2838

 



Discount Codes

Request Discount Codes
for reports of interest to you.

[email protected]
+1 212 564 2838



Browse All Reports